Table 1.
Characteristics of HCC patients.
Table 2.
Site of extrahepatic metastases in 132 HCC patients with extrahepatic metastases.
Table 3.
Univariate and multivariate analyses of predictors of survival for the HCC patients with extrahepatic metastasis.
Table 4.
Clinical profile of HCC patients with or without lymphatic metastasis.
Figure 1.
Survival curves of HCC patients.
(A) Overall survival of all the HCC patients after initial diagnosis of extrahepatic metastasis. The cumulative survival rates at 12 and 36 months were 34.4% and 9.3%, respectively. (B) Comparison of survival rates between patients with or without active intrahepatic lesions (solid line: with active intrahepatic lesions (n = 89), dash line: without active intrahepatic lesions (n = 43), P = 0.037). (C) Comparison of survival rates between patients with or without lymph node metastases (solid line: with lymph node metastases, dash line: without lymph node metastases, P = 0.036).